LaShara A Davis1,2, Tracy M Grogan3, Joy Cox4, Francis L Weng3,5. 1. Renal and Pancreas Transplant Division, Saint Barnabas Medical Center, 94 Old Short Hills Road, Livingston, NJ, 07039, USA. ldavis@barnabashealth.org. 2. School of Communication and Information, Rutgers University, 4 Huntington St, New Brunswick, NJ, 08901, USA. ldavis@barnabashealth.org. 3. Renal and Pancreas Transplant Division, Saint Barnabas Medical Center, 94 Old Short Hills Road, Livingston, NJ, 07039, USA. 4. School of Communication and Information, Rutgers University, 4 Huntington St, New Brunswick, NJ, 08901, USA. 5. Rutgers School of Public Health, Rutgers University, 683 Hoes Lane West, Piscataway, NJ, 08854, USA.
Abstract
CONTEXT: End-stage renal disease (ESRD) is more common among Blacks, but Blacks are less likely to receive a live donor kidney transplant (LDKT). OBJECTIVE: The objective of this study is to identify barriers and coping mechanisms that Black LDKT recipients and donors experienced while receiving or donating a kidney. DESIGN: A qualitative study was conducted using structured interviews. Thematic analysis was used for data interpretation. PARTICIPANTS: All 20 participants identified as Black, with two participants identifying themselves as multiracial. The mean age for the 14 recipients was 60, and the average age for the 6 living donors was 47. RESULTS: Themes emerging from the data suggest both recipients and donors faced barriers in the LDKT experience. Recipients faced barriers associated with their denial and avoidance of the severity of their ESRD, their desire to maintain the privacy of their health status, and their refusal to approach potential donors. Donors encountered negative responses from others about the donors' desire to donate and the initial refusal of recipients to accept a LDKT offer. Recipients identified faith as a coping mechanism, while donors identified normalization of donation as their method of coping. Various types of social support helped donors and recipients navigate the transplant process. CONCLUSION: Black LDKT recipients and donors must overcome barriers prior to receiving or donating a kidney. Most of these barriers arise from communication and interactions with others that are either lacking or undesirable. Future interventions to promote LDKT among Blacks may benefit by specifically targeting these barriers.
CONTEXT: End-stage renal disease (ESRD) is more common among Blacks, but Blacks are less likely to receive a live donor kidney transplant (LDKT). OBJECTIVE: The objective of this study is to identify barriers and coping mechanisms that Black LDKT recipients and donors experienced while receiving or donating a kidney. DESIGN: A qualitative study was conducted using structured interviews. Thematic analysis was used for data interpretation. PARTICIPANTS: All 20 participants identified as Black, with two participants identifying themselves as multiracial. The mean age for the 14 recipients was 60, and the average age for the 6 living donors was 47. RESULTS: Themes emerging from the data suggest both recipients and donors faced barriers in the LDKT experience. Recipients faced barriers associated with their denial and avoidance of the severity of their ESRD, their desire to maintain the privacy of their health status, and their refusal to approach potential donors. Donors encountered negative responses from others about the donors' desire to donate and the initial refusal of recipients to accept a LDKT offer. Recipients identified faith as a coping mechanism, while donors identified normalization of donation as their method of coping. Various types of social support helped donors and recipients navigate the transplant process. CONCLUSION: Black LDKT recipients and donors must overcome barriers prior to receiving or donating a kidney. Most of these barriers arise from communication and interactions with others that are either lacking or undesirable. Future interventions to promote LDKT among Blacks may benefit by specifically targeting these barriers.
Entities:
Keywords:
Barriers to donation; Barriers to transplantation; Blacks, Communication; End-stage renal disease; Living donor kidney transplant
Authors: Lianne Barnieh; Kevin McLaughlin; Braden J Manns; Scott Klarenbach; Serdar Yilmaz; Brenda R Hemmelgarn Journal: Nephrol Dial Transplant Date: 2010-07-05 Impact factor: 5.992
Authors: A J Matas; J M Smith; M A Skeans; B Thompson; S K Gustafson; D E Stewart; W S Cherikh; J L Wainright; G Boyle; J J Snyder; A K Israni; B L Kasiske Journal: Am J Transplant Date: 2015-01 Impact factor: 8.086
Authors: John C Sieverdes; Lynne S Nemeth; Gayenell S Magwood; Prabhakar K Baliga; Kenneth D Chavin; Ken J Ruggiero; Frank A Treiber Journal: Prog Transplant Date: 2015-06 Impact factor: 1.187
Authors: Leonieke W Kranenburg; Willij C Zuidema; Willem Weimar; Medard T Hilhorst; Jan N M Ijzermans; Jan Passchier; Jan J V Busschbach Journal: Transplantation Date: 2007-10-27 Impact factor: 4.939
Authors: Amy D Waterman; Sara L Stanley; Tonie Covelli; Erik Hazel; Barry A Hong; Daniel C Brennan Journal: Prog Transplant Date: 2006-03 Impact factor: 1.065
Authors: Shayna L Lunsford; Lilless M Shilling; Kenneth D Chavin; Margaret S Martin; Lucia G Miles; Michele L Norman; Prabhakar K Baliga Journal: Prog Transplant Date: 2007-09 Impact factor: 1.065
Authors: Kimberly Harding; Tesfaye B Mersha; Phuong-Thu Pham; Amy D Waterman; Fern A Webb; Joseph A Vassalotti; Susanne B Nicholas Journal: Am J Nephrol Date: 2017-08-05 Impact factor: 3.754
Authors: Nicole DePasquale; Matthew J Ellis; Debra L Sudan; Patti L Ephraim; Lisa M McElroy; Dinushika Mohottige; Clemontina A Davenport; Xiyuan Zhang; Sarah B Peskoe; Tara S Strigo; Ashley N Cabacungan; Iris Pounds; Jennie A Riley; Margaret Falkovic; L Ebony Boulware Journal: Clin Transplant Date: 2021-01-25 Impact factor: 2.863
Authors: Christine Park; Mandisa-Maia Jones; Samantha Kaplan; Felicitas L Koller; Julius M Wilder; L Ebony Boulware; Lisa M McElroy Journal: Int J Equity Health Date: 2022-02-12